These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33348693)

  • 1. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells.
    Srivastava S; Widmann S; Ho C; Nguyen D; Nguyen A; Premaratne A; Gustafsson JÅ; Lin CY
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
    Karaboga H; Huang W; Srivastava S; Widmann S; Addanki S; Gamage KT; Mazhar Z; Ebalunode JO; Briggs JM; Gustafsson JÅ; Filgueira CS; Gilbertson SR; Lin CY
    ACS Chem Biol; 2020 Nov; 15(11):2916-2928. PubMed ID: 33074669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells.
    Premaratne A; Ho C; Basu S; Khan AF; Bawa-Khalfe T; Lin CY
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.
    Candelaria NR; Addanki S; Zheng J; Nguyen-Vu T; Karaboga H; Dey P; Gabbi C; Vedin LL; Liu K; Wu W; Jonsson PK; Lin JZ; Su F; Bollu LR; Hodges SE; McElhany AL; Issazadeh MA; Fisher WE; Ittmann MM; Steffensen KR; Gustafsson JÅ; Lin CY
    PLoS One; 2014; 9(9):e106289. PubMed ID: 25184494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer.
    Wang YP; Zhou W; Wang J; Huang X; Zuo Y; Wang TS; Gao X; Xu YY; Zou SW; Liu YB; Cheng JK; Lei QY
    Mol Cell; 2016 Nov; 64(4):673-687. PubMed ID: 27840030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
    Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
    J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells.
    Abrego J; Gunda V; Vernucci E; Shukla SK; King RJ; Dasgupta A; Goode G; Murthy D; Yu F; Singh PK
    Cancer Lett; 2017 Aug; 400():37-46. PubMed ID: 28455244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for Kras
    Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P
    Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth.
    Wang VM; Ferreira RMM; Almagro J; Evan T; Legrave N; Zaw Thin M; Frith D; Carvalho J; Barry DJ; Snijders AP; Herbert E; Nye EL; MacRae JI; Behrens A
    Nat Cell Biol; 2019 Nov; 21(11):1425-1435. PubMed ID: 31685994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
    Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
    Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
    Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
    Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification.
    Wu YS; Looi CY; Subramaniam KS; Masamune A; Chung I
    Oncotarget; 2016 Jun; 7(24):36719-36732. PubMed ID: 27167341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer.
    Recouvreux MV; Moldenhauer MR; Galenkamp KMO; Jung M; James B; Zhang Y; Lowy A; Bagchi A; Commisso C
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32510550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition.
    Jeong SM; Hwang S; Park K; Yang S; Seong RH
    Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.
    Onishi H; Kai M; Odate S; Iwasaki H; Morifuji Y; Ogino T; Morisaki T; Nakashima Y; Katano M
    Cancer Sci; 2011 Jun; 102(6):1144-50. PubMed ID: 21338440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism.
    Sun W; Luan S; Qi C; Tong Q; Yan S; Li H; Zhang Y
    Cell Commun Signal; 2019 Aug; 17(1):111. PubMed ID: 31470862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways.
    Yang S; Tang W; Azizian A; Gaedcke J; Ohara Y; Cawley H; Hanna N; Ghadimi M; Lal T; Sen S; Creighton CJ; Gao J; Putluri N; Ambs S; Hussain P
    Carcinogenesis; 2024 Aug; 45(8):582-594. PubMed ID: 38629149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.